Spin-Out A Neat Solution For Sanofi’s Manufacturing Millstone
Bypasses Union Objections To Downsizing
Hudson finds solution for legacy sites which have dogged predecessors.
You may also be interested in...
Sanofi has announced plans to create the world’s second-largest API manufacturer to help ease European drugmakers’ dependence on supplies of raw materials from China and India.
The French drugmaker ended 2019 with a solid Q4 performance and news that its BTK inhibitor SAR442168 will start Phase III testing in progressive and elapsing multiple sclerosis.
The VC firm is making the most of a surge of capital from new and established investors who believe in the promise of European biopharma start-ups.